Connect with us

HealthBiz

Samsung Biologics launches S-CHOice cell line expression technology

Published

on

Samsung Biologics launches S-CHOice cell line expression technology

Samsung Biologics (KRX: 207940.KS) today held an online ceremony to announce the launch of its proprietary cell line technology, S-CHOice.


S-CHOice builds on glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line technology and shows improved titers up to two-fold from industry average, reaching above 7 g/L for standard monoclonal antibodies. The cell line also shows enhanced cell viability with over 90% at day-21 in a fed-batch study, demonstrating effectiveness in producing high quality cell lines.

Moreover, S-CHOice has a speedy cell division of 18-20 hours and together with Berkeley Lights Beacon® technology, Samsung Biologics can offer reduced development timeline by a month from the industry average of four to five months.

The company will also provide attractive payment terms for clients choosing to use this cell line technology for their future development.

Leveraging these combination of advantages, Samsung Biologics recently signed a development contract with a client under which S-CHOice will be used to advance its cell line development.

“We are extremely proud to announce the official launch of our own proprietary cell line, S-CHOice,” said Dr. Tae Han Kim, CEO of Samsung Biologics. “With this advanced, high performance technology, we can now offer our CDO clients with even more promising options in bringing their molecule faster and better to the market and ensure world-class client satisfaction during this continuously evolving global climate.”

HealthBiz

Lloyd Armbrust’s Armbrust American Debuts New Surgical Mask Colors as Demand Rises

Published

on

Lloyd Armbrust’s Armbrust American Debuts New Surgical Mask Colors as Demand Rises

As wearing face coverings become the norm for society during the pandemic, Armbrust American is excited to announce that its FDA-registered surgical masks will now be available in six vibrant new colors. The masks have the same 98% effectiveness rating for blocking particulate matter, such as the novel coronavirus, while allowing the wearer a greater degree of self-expression like with cloth face coverings.

“People in the mask world thought I was crazy for making lab-tested surgical masks in cool colors instead of the usual ‘medical blue’ or aqua green, but it makes too much sense not to,” said founder and CEO Lloyd Armbrust. “Now there’s a safer, more effective option for people wearing cloth masks that match their favorite sports team or school colors, or businesses to replace workers’ cloth face coverings with surgical masks matching the brand identity.”

The new mask color options are available for pre-order immediately, with delivery dates in the next two weeks. Colors include “Creamsicle,” “Coral,” “Sea Foam,” “American Denim,” “Pretty In Pink,” and “Charcoal.” The company is currently selling packs of 10 to determine which colors get the most traction, with plans to offer larger bundles of the most popular colors.

Research backed by the Center for Disease Control now shows that wearing masks can drastically reduce the spread of COVID-19 across the country, with surgical masks being more effective than cloth. However, getting the majority of people in the U.S. to wear them has proved challenging, which is one area American manufacturing can help correct.

“The advantage of American manufacturing is being able to understand the market and make changes to your products quickly. Since most masks are made in China and sold to resellers, it probably doesn’t make financial sense to offer more than one ugly color,” Armbrust explained. “If adding new color options gets more people wearing masks, then it becomes more than just a cosmetic change, not to mention a true testament to the need for strategic manufacturing to return to the U.S.”

Continue Reading

Trending

Copyright © 2020. All Biz Post